In health care, perhaps no word sends a more chilling message than "cancer." Brain tumors, for example, prove especially resistant to current treatments. Only 5% of patients with that condition survive more than three years ...
May 12, 2022
0
0
Inhibitors of the protein EZH2 are effective against cancers with SMARCB1 mutations such as rhabdoid tumors in children. However, these drugs are subject to treatment resistance. Scientists at St. Jude Children's Research ...
May 9, 2022
0
26
Scientists have analyzed the full genetic blueprints of more than 18,000 cancer samples, finding new patterns of mutations that could help doctors provide better, more personalized treatment.
Apr 23, 2022
0
3
A team led by researchers at Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Harvard Medical School has developed a new method to identify thousands of DNA mutations accurately and efficiently in a patient's ...
Mar 18, 2022
0
106
The clinical trial of an old antibiotic for a new purpose is offering hope to thousands of patients with drug-resistant breast cancer whose early remissions have given way to resurgent tumors.
Mar 15, 2022
0
3
Acral melanoma is a rare subtype that represents roughly 3% of all melanoma cases. Unlike typical melanoma that occurs on sun-exposed skin, acral melanoma develops on the nonhair bearing skin of the soles, palm and nail beds. ...
Mar 11, 2022
0
68
The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—today announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Ampullary Adenocarcinoma. ...
Mar 9, 2022
0
2
A new study adds to a growing body of evidence that organoids—lab-grown collections of cells that mimic a patient's tumor—are a promising avenue for drug discovery to improve outcomes in patients with cancer, particularly ...
Feb 16, 2022
0
27
A group of researchers at Qatar Foundation led by Dr. Lotfi Chouchane from Weill Cornell Medicine—Qatar (WCM-Q) have reported the first landscape of cancer germline variation in the Middle East that has been published online ...
Feb 10, 2022
0
3
A revolutionary new way of caring for people with neuroendocrine tumors (NETs) will be trialed in the coming months, with the Flinders University-led project aiming to improve patient quality of life and develop a cost-effective ...
Jan 10, 2022
0
2
